P49 The efficacy and safety of Tideglusib in a randomized, placebo-controlled, double blind study in children and adolescents with congenital myotonic dystrophy (REACH CDM study)
| Autor: | Horrigan, J., Snape, M., Fantelli, E. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2023 33 Supplement 1:S70-S71 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect